- Home
- REAL vs VYGR Comparison
REAL vs VYGR Comparison
Compare REAL & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- VYGR
- Stock Information
- Founded
- REAL 2011
- VYGR 2013
- Country
- REAL United States
- VYGR United States
- Employees
- REAL N/A
- VYGR N/A
- Industry
- REAL Other Specialty Stores
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- REAL Consumer Discretionary
- VYGR Health Care
- Exchange
- REAL Nasdaq
- VYGR Nasdaq
- Market Cap
- REAL 641.9M
- VYGR 156.0M
- IPO Year
- REAL 2019
- VYGR 2015
- Fundamental
- Price
- REAL $4.87
- VYGR $2.97
- Analyst Decision
- REAL Buy
- VYGR Strong Buy
- Analyst Count
- REAL 5
- VYGR 8
- Target Price
- REAL $8.40
- VYGR $14.33
- AVG Volume (30 Days)
- REAL 2.9M
- VYGR 931.8K
- Earning Date
- REAL 08-05-2025
- VYGR 08-05-2025
- Dividend Yield
- REAL N/A
- VYGR N/A
- EPS Growth
- REAL N/A
- VYGR N/A
- EPS
- REAL N/A
- VYGR N/A
- Revenue
- REAL $616,717,000.00
- VYGR $66,958,000.00
- Revenue This Year
- REAL $11.70
- VYGR N/A
- Revenue Next Year
- REAL $10.10
- VYGR $78.88
- P/E Ratio
- REAL N/A
- VYGR N/A
- Revenue Growth
- REAL 11.89
- VYGR N/A
- 52 Week Low
- REAL $2.24
- VYGR $2.65
- 52 Week High
- REAL $11.38
- VYGR $9.55
- Technical
- Relative Strength Index (RSI)
- REAL 41.51
- VYGR 42.80
- Support Level
- REAL $4.70
- VYGR $2.83
- Resistance Level
- REAL $5.22
- VYGR $3.09
- Average True Range (ATR)
- REAL 0.29
- VYGR 0.22
- MACD
- REAL -0.05
- VYGR -0.03
- Stochastic Oscillator
- REAL 11.52
- VYGR 17.28
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.